Ligand Pharmaceuticals Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	3,054	2,877	2,544	2,016	1,509	1,127
Revenue Growth (YoY)	12.83%	13.10%	26.17%	33.56%	33.90%	-
Cost of Revenue	1,807	1,707	1,501	1,183	862.54	657.03
Gross Profit	1,247	1,170	1,043	833.45	646.95	470.3
Selling, General & Admin	1,123	1,067	940.2	748.64	566.66	440.45
Operating Expenses	1,126	1,070	939.97	749.15	566.73	440.45
Operating Income	121.41	100.55	102.8	84.3	80.23	29.86
Interest Expense	-35.64	-36.19	-37.43	-31.98	-23.46	-22.37
Interest & Investment Income	1.84	1.52	1.42	0.56	0.2	0.15
Earnings From Equity Investments	-0.43	1.01	3.89	1.21	-	-
Currency Exchange Gain (Loss)	1.24	1.24	-0.86	-0.59	-0.76	0.02
Other Non Operating Income (Expenses)	10.06	19.88	13.16	10.85	14.19	3.49
EBT Excluding Unusual Items	98.49	88.01	82.98	64.34	70.4	11.14
Gain (Loss) on Sale of Investments	9.84	9.84	-	-	-	-
Gain (Loss) on Sale of Assets	0.99	0.99	-0.22	-0.03	-6.99	-0.34
Other Unusual Items	2.27	2.27	0.06	0.56	0.78	3.35
Pretax Income	111.59	101.11	82.82	64.87	64.19	14.15
Income Tax Expense	4.44	0.31	-0.28	-1.84	0.15	1.56
Earnings From Continuing Operations	107.16	100.81	83.1	66.71	64.04	12.59
Minority Interest in Earnings	-0.08	0.02	-0.02	-0	-	-2.38
Net Income	107.08	100.83	83.08	66.71	64.04	10.2
Net Income to Common	107.08	100.83	83.08	66.71	64.04	10.2
Net Income Growth	18.52%	21.37%	24.54%	4.16%	527.64%	-
Shares Outstanding (Basic)	44	42	39	33	33	30
Shares Outstanding (Diluted)	44	42	40	34	33	30
Shares Change (YoY)	8.69%	6.22%	15.55%	5.08%	8.42%	-
EPS (Basic)	2.43	2.39	2.12	2.02	1.96	0.34
EPS (Diluted)	2.43	2.39	2.09	1.94	1.96	0.33
EPS Growth	9.27%	14.49%	7.57%	-0.76%	486.87%	-
Free Cash Flow	321.02	223.26	214.17	10.92	259.67	161.95
Free Cash Flow Per Share	7.27	5.29	5.39	0.32	7.93	5.36
Dividend Per Share	0.980	0.980	0.980	0.686	-	-
Dividend Growth	-	-	42.85%	-	-	-
Gross Margin	40.84%	40.67%	40.99%	41.34%	42.86%	41.72%
Operating Margin	3.98%	3.50%	4.04%	4.18%	5.32%	2.65%
Profit Margin	3.51%	3.50%	3.27%	3.31%	4.24%	0.91%
Free Cash Flow Margin	10.51%	7.76%	8.42%	0.54%	17.20%	14.37%
EBITDA	211.67	167.31	165.19	132.41	117.7	60.17
EBITDA Margin	6.93%	5.82%	6.49%	6.57%	7.80%	5.34%
D&A For EBITDA	90.26	66.76	62.39	48.11	37.47	30.32
EBIT	121.41	100.55	102.8	84.3	80.23	29.86
EBIT Margin	3.98%	3.50%	4.04%	4.18%	5.32%	2.65%
Effective Tax Rate	3.97%	0.30%	-	-	0.23%	11.05%

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.